Description

Book Synopsis
FDA has taken some steps to identify and act upon safety concerns related to dietary supplements; however, several factors limit the agency''s ability to detect concerns and remove products from the market. For example, FDA has limited information on the number and location of dietary supplement firms, the types of products currently available in the marketplace, and information about moderate and mild adverse events reported to industry. Additionally, FDA dedicates relatively few resources to oversight activities, such as providing guidance to industry regarding notification requirements for products containing new dietary ingredients. This book highlights the limited steps taken by the FDA to educate consumers about dietary supplements and their risks. This book consists of public documents which have been located, gathered, combined, reformatted, and enhanced with a subject index, selectively edited and bound to provide easy access.

Dietary Supplements: Primer & FDA Oversight

    Product form

    A Hardback by Timothy H Riley

    £85.59

    Includes FREE delivery

    RRP £106.99 – you save £21.40 (20%)

    Order before 4pm today for delivery by Tue 1 Sep 2026.

    1 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Dietary Supplements: Primer & FDA Oversight by Timothy H Riley

      Book details

      Publisher Nova Science Publishers Inc
      Published 21 May 2010
      ISBN-13 9781607418917
      978-1607418917
      ISBN-10 1607418916
      Also in:
      Dietetics and nutrition

      Description

      Book Synopsis
      FDA has taken some steps to identify and act upon safety concerns related to dietary supplements; however, several factors limit the agency''s ability to detect concerns and remove products from the market. For example, FDA has limited information on the number and location of dietary supplement firms, the types of products currently available in the marketplace, and information about moderate and mild adverse events reported to industry. Additionally, FDA dedicates relatively few resources to oversight activities, such as providing guidance to industry regarding notification requirements for products containing new dietary ingredients. This book highlights the limited steps taken by the FDA to educate consumers about dietary supplements and their risks. This book consists of public documents which have been located, gathered, combined, reformatted, and enhanced with a subject index, selectively edited and bound to provide easy access.

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account